Compare BRFH & ICCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BRFH | ICCC |
|---|---|---|
| Founded | 2005 | 1982 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Packaged Foods | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 49.7M | 55.5M |
| IPO Year | N/A | 1987 |
| Metric | BRFH | ICCC |
|---|---|---|
| Price | $3.25 | $6.58 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $6.00 | N/A |
| AVG Volume (30 Days) | 14.6K | ★ 40.9K |
| Earning Date | 11-06-2025 | 02-25-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.26 |
| Revenue | $11,574,000.00 | ★ $27,769,304.00 |
| Revenue This Year | $37.56 | N/A |
| Revenue Next Year | $101.44 | N/A |
| P/E Ratio | ★ N/A | $24.63 |
| Revenue Growth | ★ 17.49 | 16.49 |
| 52 Week Low | $2.00 | $4.28 |
| 52 Week High | $6.08 | $7.60 |
| Indicator | BRFH | ICCC |
|---|---|---|
| Relative Strength Index (RSI) | 56.96 | 56.16 |
| Support Level | $2.88 | $6.15 |
| Resistance Level | $3.44 | $6.89 |
| Average True Range (ATR) | 0.17 | 0.33 |
| MACD | 0.05 | 0.02 |
| Stochastic Oscillator | 87.14 | 55.86 |
Barfresh Food Group Inc develops, manufactures and distributes ready to blend frozen beverages, including smoothies, shakes and frappes for restaurant chains and the foodservice industry. The company's proprietary, patented system uses portion-controlled pre-packaged beverage ingredients that deliver freshly made frozen beverages that are quick, cost efficient, and without waste. Barfresh provides both a single serve solution and a bulk format solution, ideal for high-volume locations. It has seven flavors available as part of its standard line vanilla shake, caribbean smoothie, triple berry smoothie, caramel macchiato frappe, strawberry banana smoothie, mocha frappe and mango burst smoothie and has the development capabilities to deliver custom flavors.
ImmuCell Corp is engaged in the healthcare sector. The company operates in the development, acquisition, manufacture, and sale of products that improve the health and productivity of cows for the dairy and beef industries. The company operates in two business segment. The Scours segment is dedicated to manufacturing and selling First Defense, a product used to prevent scours in newborn calves, which is regulated by the United States Department of Agriculture (USDA). The Mastitis segment is focused on developing and commercializing Re-Tain, a product to treat subclinical mastitis in lactating dairy cows, which is regulated by the United States Food and Drug Administration (FDA). The company generates the majority of its revenue from the Scours segment.